sb.scorecardresearch
Advertisement

Published 14:51 IST, September 15th 2023

Strides Pharma hits fresh 52-week high after tentative US FDA nod for Dolutegravir tablets

The stocks of the company were trading over 9.50 per cent higher at Rs 513 per share, as of 11:23 am, on BSE.

Reported by: Tanmay Tiwary
Follow: Google News Icon
  • share
Strides Pharma
Image Credits: Republic | Image: self
Advertisement

12:16 IST, September 15th 2023